Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10399741 | 0.97 | EPHX1 (0.73) | EPHX1EPHX2MEN1KMT2APRMT1 | |
| SCHEMBL13135023 | 0.94 | EPHX1 (0.61) | EPHX1EPHX2MEN1KMT2APRMT1 | |
| SCHEMBL1753987 | 0.93 | EPHX1 (0.82) | EPHX1EPHX2 | |
| SCHEMBL25227718 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL14424719 | 0.91 | EPHX1 (0.58) | EPHX1EPHX2MEN1KMT2APRMT1 | |
| SCHEMBL6285139 | 0.91 | EPHX1 (0.58) | EPHX1EPHX2MEN1KMT2APRMT1 | |
| SCHEMBL25274521 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL25270954 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL11236288 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL8392235 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080093301-A1 | Disubstituted Cucurbituril-Bonded Silica Gel | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080093301-A1 | Disubstituted Cucurbituril-Bonded Silica Gel | SOD1, SPECC1L, MSRB3 | EPHX1 3955/4885EPHX2 2817/4885MEN1 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.